Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.06 USD | +1.92% |
|
+10.35% | -85.28% |
Jul. 09 | AEON Biopharma Plans to Pursue Biosimilar Regulatory Pathway for ABP-450 | MT |
Jul. 09 | AEON Biopharma, Inc. Announces Strategic Reprioritization to Pursue A Biosimilar Pathway for ABP-450 | CI |
- Stock Market
- Equities
- AEON Stock
- News AEON Biopharma, Inc.
- Trading Ideas